Laboratory

An assessed value or quality score applied to a microbiology finding, laboratory process, or specimen quality, such as a Gram stain adequacy rating, culture result confidence level, or susceptibility testing interpretation score. Used to evaluate the reliability and clinical utility of microbiological laboratory results.

A proportional value derived from microbiology data, such as the ratio of resistant to susceptible isolates within a facility's antibiogram, the proportion of positive cultures among tested specimens, or quantitative relationships between organism concentrations used in clinical interpretation of infection severity and laboratory findings.

The clinical explanation or indication documented for ordering a microbiology test, culture, or susceptibility study, such as suspected urinary tract infection, fever of unknown origin, or wound infection evaluation. Supports medical necessity documentation, laboratory order justification, and downstream claims billing for diagnostic microbiology services.

The date on which a clinical specimen was received and accessioned by the microbiology laboratory for processing, culture, or pathogen identification. Used to calculate turnaround time, assess specimen viability and integrity, and establish the timeline of laboratory events relative to patient infection onset and clinical treatment decisions.

An external identifier or pointer linking a microbiology result, specimen, or culture record to a related document, accession number, ordering system record, or external reference database such as SNOMED CT or LOINC. Enables cross-system traceability of microbiology data across laboratory information systems and clinical records.

The date on which a microbial infection, positive culture finding, or microorganism-related clinical condition was considered resolved, cleared, or no longer clinically active. Used in infection surveillance, antimicrobial stewardship programs, and longitudinal patient records to document the duration and outcome of treated microbial infections.

The patient's respiratory rate recorded in association with a microbiology encounter or infectious disease evaluation, used as a systemic indicator when assessing sepsis criteria, pneumonia severity, or the physiologic burden of an active microbial infection on pulmonary function during clinical management and monitoring.

The reported outcome of a microbiology laboratory test, including organism identification, colony counts, antimicrobial susceptibility findings, or culture results. Documents whether pathogens were detected and their clinical significance for infection diagnosis and treatment decisions.

The body systems evaluated during clinical review of microbiology findings, such as respiratory, genitourinary, or gastrointestinal systems. Used to correlate laboratory culture and sensitivity results with patient symptomatology and guide targeted antimicrobial therapy selection.

The version or iteration number tracking amendments to a microbiology report, such as updated organism identification, corrected susceptibility panels, or addended culture results. Ensures clinicians reference the most current and accurate laboratory findings when making treatment decisions.

The assessed danger level associated with a microbiology finding, including infection transmission risk, pathogen virulence classification, or patient susceptibility factors. Informs infection control protocols, isolation precautions, and public health reporting requirements for identified organisms.

The anatomical pathway or site through which a specimen was collected or infection is transmitted, such as respiratory, bloodstream, wound, or urinary tract. Critical for correlating culture source with clinical presentation and selecting appropriate antimicrobial therapy routes.

A calculated numeric rating derived from microbiology findings, such as bacterial load quantification, biofilm scores, or composite infection severity indices. Used to standardize assessment of culture results and support clinical decision-making for antimicrobial treatment thresholds.

The sequential ordering number assigned to microbiology tests, specimens, or results within a patient encounter or laboratory workflow. Tracks the chronological progression of cultures, serial susceptibility testing, and repeat specimens to monitor treatment response over time.

The calendar date on which microbiology laboratory services were rendered, including specimen collection, culture processing, or result reporting. Used to establish clinical timelines for infection onset, treatment initiation, and regulatory compliance with laboratory turnaround standards.

The clinical seriousness classification of a microbiology finding, reflecting pathogen virulence, infection extent, or degree of antimicrobial resistance. Guides escalation decisions such as hospital admission, intensive care placement, or initiation of broad-spectrum antimicrobial coverage.

The patient's biological sex recorded in association with a microbiology encounter, used to contextualize culture results for sex-specific infections such as urinary tract infections, sexually transmitted infections, or reproductive tract cultures in clinical data analysis.

The anatomical site or specimen type from which a microbiology sample was collected, such as blood, urine, wound swab, cerebrospinal fluid, or sputum. Essential for interpreting culture results, determining organism clinical relevance, and differentiating true infection from contamination.

The date marking the initiation of microbiology testing or the onset of a documented infection episode. Used to calculate culture turnaround times, track infection duration, and establish clinical timelines for antimicrobial stewardship and epidemiological surveillance reporting.

The precise time at which a microbiology specimen collection or culture processing began. Critical for calculating laboratory turnaround performance, monitoring time-sensitive infections such as sepsis, and ensuring compliance with clinical protocols requiring timely specimen handling.